Press Releases :: Moleculin Biotech, Inc. (MBRX)

Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer

Feb 13, 2018

Moleculin Announces Activity with Pancreatic Cancer Drug

Feb 7, 2018

Leading Leukemia Experts Join Moleculin's Science Advisory Board

Jan 17, 2018

Moleculin Expands Leukemia Development Portfolio with Immuno-Stimulating STAT3 Inhibitor

Jan 10, 2018

Moleculin Announces Polish Approval for Leukemia Clinical Trial

Dec 21, 2017

Moleculin's WP1066 Drug receives $2 million Private Grant

Dec 6, 2017

Moleculin's WP1066 Drug gets FDA Brain Tumor IND Clearance

Dec 5, 2017

Moleculin to Present at the 10th Annual LD Micro Main Event on December 5, 2017 at 11:30 a.m. PT

Nov 21, 2017

Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2017

Nov 14, 2017

Moleculin Appoints Dr. Sandra Silberman as Chief Medical Officer -- New Products

Nov 8, 2017